FNDC3B and pachyonychia congenita: Furthermore, elevated FNDC3B expression correlated with reduced PFI in PC patients without radiation therapy but having achieved CR for primary therapy outcome while being male individuals aged ≤ 65 years old with white race and R0 residual tumor status along with histologic grade G1 or other anatomic neoplasm subdivisions (Fig. 5R–Y, P < 0.05).